tiprankstipranks
Trending News
More News >
Teva Pharmaceutical (TEVA)
NYSE:TEVA
US Market

Teva Pharmaceutical (TEVA) Income Statement

Compare
7,627 Followers

Teva Pharmaceutical Income Statement

Last quarter (Q3 2025), Teva Pharmaceutical's total revenue was $4.48B, an increase of 3.44% from the same quarter last year. In Q3, Teva Pharmaceutical's net income was $433.00M. See Teva Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 16.54B$ 15.85B$ 14.93B$ 15.88B$ 16.66B
Gross Profit
$ 8.06B$ 7.64B$ 6.97B$ 7.59B$ 7.73B
Operating Expenses
$ 8.37B$ 7.21B$ 9.17B$ 5.88B$ 11.30B
Depreciation and Amortization
$ 1.06B$ 1.15B$ 1.31B$ 1.33B$ 1.56B
EBITDA
$ 4.43B$ 1.56B$ -925.00M$ 4.41B$ 4.61B
Operating Income
$ -303.00M$ 433.00M$ -2.20B$ 1.72B$ -3.57B
Other Income/Expenses
$ -980.00M$ -1.05B$ -945.00M$ -1.05B$ -359.00M
Pretax Income
$ -1.28B$ -622.00M$ -3.14B$ 667.00M$ -3.93B
Net Income
$ -1.64B$ -559.00M$ -2.45B$ 417.00M$ -3.99B
Per Share Metrics
Basic EPS
$ -1.45$ -0.50$ -2.20$ 0.38$ -3.64
Diluted EPS
$ -1.45$ -0.50$ -2.20$ 0.38$ -3.64
Weighted Average Shares Outstanding
1.13B 1.12B 1.11B 1.10B 1.09B
Weighted Average Shares Outstanding (Diluted)
1.13B 1.12B 1.11B 1.11B 1.09B
Currency in USD

Teva Pharmaceutical Earnings and Revenue History